Emerging ResearchLegal to Compound
BPC-157 Dosing Guide
Evidence-based dosing protocols across 2 administration approaches.
Medical Disclaimer
This dosing information is for educational reference only. Dosing decisions require physician oversight. Do not self-prescribe or adjust dosing without consulting a qualified healthcare provider.
Dosing Protocols
Tissue Repair (Clinic Protocol)
Animal DataSubcutaneousDose Range
200–500 mcg
Frequency
daily
Duration
4-8 weeks, then 2-4 weeks off
Source
PMC9794587 (PK in rats/dogs); Orthopaedic systematic review PMC12313605
PRIMARILY ANIMAL DATA. Only 1 registered Phase I trial (cancelled 2016). Only 3 small published human studies. Weight-based: <150 lb → 200-300 mcg; 150-200 lb → 300-400 mcg; >200 lb → 400-500 mcg. Inject near injury site when possible. FDA Category 2 (banned from US compounding Sept 2023).
GI Healing (Oral)
Animal DataOralDose Range
250–500 mcg
Frequency
daily
Lower systemic bioavailability via oral route. Used for GI-specific applications.
Administration
Delivery methods
Subcutaneous injectionOral (capsule)Intramuscular injection
⏳
Pending physician review — consult your provider before use.Updated 2026-04-10